Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Hepatology patients needed..

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Jun 15, 2021 11:18am

93 Views

Post# 33388369

RE:RE:RE:RE:Hepatology patients needed..

This update is clearly in the IR/messaging category. Given the timing it has me thinking the KOL event is part of the same strategy rather than being a data-driven event. It could still be both but it's looking to me more like a primer for what should begin to emerge later in the summer (???).

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features